Biventricular Longitudinal Strain Predict Mortality in COVID-19 Patients
Yuji Xie1,2, Lufang Wang1,2, Meng Li1,2
1Department of Ultrasound, Tongji Medical College, Union Hospital, Huazhong University of Science and Technology, Wuhan, China.
Biventricular longitudinal strain, including left and right ventricular measures, predicts mortality in COVID-19 patients. Impaired strain indicates higher risk, while improvement suggests recovery, aiding in risk stratification.
Area of Science:
- Cardiology
- Infectious Diseases
- Echocardiography
Background:
- Biventricular longitudinal strain is a known predictor of adverse outcomes in cardiovascular diseases.
- The prognostic value of biventricular longitudinal strain in coronavirus disease 2019 (COVID-19) remains under investigation.
Purpose of the Study:
- To evaluate the prognostic significance of biventricular longitudinal strain in patients diagnosed with COVID-19.
- To determine if left ventricular global longitudinal strain (LV GLS4CH) and right ventricular free wall longitudinal strain (RV FWLS) can predict mortality in COVID-19.
Main Methods:
- 132 consecutive patients with COVID-19 were analyzed.
- Two-dimensional speckle-tracking echocardiography was used to measure LV GLS4CH and RV FWLS.
- Correlation with inflammatory biomarkers, coagulopathy, and clinical outcomes including mortality was assessed.
Main Results:
- Patients with cardiac injury showed decreased LV GLS4CH and RV FWLS, elevated inflammatory markers, and higher mortality.
- Impaired LV GLS4CH and RV FWLS were significantly associated with increased mortality during hospitalization.
- LV GLS4CH and RV FWLS demonstrated significant improvement at 3-month follow-up in survivors.
Conclusions:
- LV GLS4CH and RV FWLS are independent predictors of mortality in COVID-19 patients.
- Biventricular longitudinal strain measurements are valuable for risk stratification and monitoring recovery in COVID-19.
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Heart Failure II: Pathophysiology
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Mitral Stenosis III: Medical Management
Mitral Stenosis II: Clinical features and Diagnostic Tests
Cardiomyopathy IV: Restrictive Cardiomyopathy


